跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
COMBOGESIC - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
COMBOGESIC
Authorized
STANDARD
COMBOGESIC
biosyent pharma inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
97d6ab8c2d82920b
Company
biosyent pharma inc
Type
Standard
Approval Details
Approval Id
97d6ab8c2d82920b
Drug Approval Canada Name
COMBOGESIC
Product Name
COMBOGESIC
Status
Marketed
Status Date
2020-12-14
Original Market Date
2020-12-14
Din
02488280
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
OTC
Ahfs
28:08.92
Atc Original
N02BE51 ACETAMINOPHEN, COMB EXCL PSYCHOLEPTICS
Atc Name
n 02 be 51
Aig Number
0261410001
Company Name
biosyent pharma inc
Company Address
SUITE 402, 2476 Argentia Road, Mississauga, Ontario, Canada, L5N 6M1
Active Ingredients
ACETAMINOPHEN
325 MG
IBUPROFEN
97.5 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
97d6ab8c2d82920b
Type
Standard
Back to Health Canada Approvals